Michael Thomas Heneka - Curriculum Vitae#

Education:

• 1990 - 1996 Medical Course, University of Tübingen, Germany, MD thesis at the Dept. of Pharmacology and Toxicology, Grade “summa cum laude”
  
• 1996 - 2002 Specialisation and board examination in neurology
  
• 2003 Habilitation for Neurology “Inflammatory mechanisms of Alzheimer`s disease: characterisation and development of therapeutic strategies”

Appointments:

• 1996 – 1998 Postdoctoral fellow, Department of Neurology, University of Tübingen
  
• 1999 – 2003 Clinical resident, Department of Neurology, University of Bonn
  
• 2003 –2003 Postdoctoral fellow, Dept. of Neuroscience, Case Western Reserve University, Cleveland, USA
  
• 2004 – 2004 Senior clinical fellow, Department of Neurology, University of Bonn
  
• 2004 – 2008 Full Prof. of Neurology, Head of the Molecular Neurology Unit at the Dept. of Neurology, University of Münster
  
• since May 2007 Board member, German Ministry of Research and Education “Network of competence for neurodegenerative dementias”
  
• since Juli 2007 Head, DFG-Clinical Research Center KFO 177 “Innate Immunity in Chronic Neurodegeneration”.
  
• since March 2008 Full.-Prof. of Clinical Neuroscience, Dept. of Neurology, University of Bonn
  
• Director of the Clinical Neurosciences Unit (CNU)
  
• Head of the Neurodegeneration Outpatient Unit (KBFZ)
  
• since April 2010 Affiliation at the DZNE (German Centre for Neurodegenerative Disease) with responsibilities for neuroinflammation, the biomarker and intervention program

Clinical Studies as principal investigator:

• Alzheimer disease
  
  • Ozarelix: ZEN-006-Z030; ENA713 Exelon® Patch Rivastigmine, MRZ90001-0608/1, Wyeth Elan ACC 001, NOVARTIS CCAD106A2203 study, Noscira ARGO Study
    
• Amyotrophic Lateral Sclerosis:
  
  • GERPALS EudraCT number: 2006-005410-13

Clinical Advisory panels/ Industrial Consultancy:

Pfizer, Wyeth, Bayer Schering, Novartis, Genfit

Honours and special recognitions:

• 1998 Thesis award, University of Tübingen
  
• 2011 Christa-Lorenz-Price for ALS Research
  

Memberships:

Society for Neuroscience (SFN), American Society for Neurochemistry (ASN),International Society for Neurochemistry (ISN),German Society for Neurology (DGN)

Patents:

• WO 2005/016339 A1, “Antiinflammatory methods for treatment of Parkinson`s disease”, together with Prof. G.E. Landreth.
  
• EP09009085.3a: Inhibitors of the nitration of amyloid beta peptides and their uses in the diagnosis and treatment of Alzheimer's disease, 2009
  

Ad-hoc Reviewer for international journals:

PNAS, Journal of Clinical Investigation, Journal of Expeirmental Medicine, Journal of Neuroscience, Brain, Journal of Biological Chemistry, Journal of Immunology, Journal of Neurochemistry, Glia, Experimental Neurology,European Journal of Neuroscience, Neurobiology of Aging, British Journal of Pharmacology, Molecular Pharmacology, a.o.

Ad-hoc Reviewer for scientific organisations (national/internaltional):

German Research Council (DFG, Germany), Fonds zur Förderung der Wissenschaft (Austria), Agence Nationale de la Recherche (France), Health Research Board (Ireland) Alexander von Humboldt Stiftung (Germany), American Alzheimer Association (USA), Wellcome Trust (UK), Cancer Research UK (UK), Medical Research Council (MRC, UK), SAO-FRMA.

Editorial boards:

• Journal of Chemical Neuroanatomy
  
• Journal of Neurochemistry
  
• Molecular Neurobiology